Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cdk4 inhibitor'

Search results for: 'cdk4 inhibitor'

Items 21-30 of 120

Page
per page
  1. Salinosporamide A (NPI-0052, Marizomib)
    A4010 Salinosporamide A (NPI-0052, Marizomib)
    Target: Proteasome
    Summary: 20S proteasome inhibitor
      Soluble in DMSO
  2. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  3. NH125
    A8814 NH125
     1 Citation
    Target: eEF-2
    Summary: Selective eEF-2 kinase inhibitor
      ≥25.9 mg/mL
  4. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  5. LGK-974
    B2307 LGK-974
     1 Citation
    Summary: PORCN inhibitor,potent and specific
      insoluble in H2O; ≥19.8 mg/mL
  6. CGK733
    A8624 CGK733
    Target: ATM/ATR
    Summary: ATM/ATR inhibitor,potent and selective
      ≥27.8 mg/mL
  7. GSK2126458
    A8556 GSK2126458
     1 Citation
    Target: PI3K|mTOR
    Summary: PI3K/mTOR inhibitor
      ≥25.3 mg/mL
  8. AZD8330
    A8374 AZD8330
    Target: MEK
    Summary: MEK 1/2 inhibitor
      ≥23.05 mg/mL
  9. Abiraterone acetate
    A8202 Abiraterone acetate
    Target: Cytochrome P450 (CYP450)
    Summary: Cytochrome p450 17a1 inhibitor
      insoluble in H2O; ≥11.22 mg/mL
  10. 3-Methyladenine
    A8353 3-Methyladenine
     3 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL

Items 21-30 of 120

Page
per page
Shop By
Now Shopping by
  1. Related Disease Breast Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 117item
Specificity
  1. Selective 115item
Reversibility
  1. Reversible 9item
  2. Irreversible 3item
Target
  1. Cyclin-Dependent Kinases 6item
  2. Proteasome 2item
  3. Cathepsins 1 item
  4. Histone Deacetylases (HDACs) 10item
  5. Inhibitor of apoptosis proteins (IAP) 1 item
  6. Akt 3item
  7. Bcl-2 2item
  8. PI3K 8item
  9. CXCR 2item
  10. Aurora Kinases 4item
  11. Bcl-xl 2item
  12. CSF-1R 1 item
  13. EZH2 2item
  14. mTOR 5item
  15. Bromodomains 1 item
  16. DT-diaphorases 1 item
  17. FLT3 2item
  18. P-glycoprotein (P-gp) 1 item
  19. PLK 1 item
  20. Chk 1 item
  21. VEGFR 9item
  22. PDGFR 4item
  23. c-Kit 3item
  24. Mcl-1 2item
  25. Thymidylate Synthase 1 item
  26. p38 1 item
  27. 3-phosphoglycerate dehydrogenase 1 item
  28. Bcr-Abl 1 item
  29. MEK 5item
  30. PORCN 1 item
  31. FGFR 2item
  32. Pim 2item
  33. Smoothened 1 item
  34. MET 1 item
  35. Src 1 item
  36. Trk Receptors 1 item
  37. STAT 2item
  38. Microtubules/Tubulins 1 item
  39. EGFR 8item
  40. FAK 1 item
  41. BMP and Other Activin Receptors 1 item
  42. JAK 2item
  43. Syk 1 item
  44. HSP90 5item
  45. Topoisomerases 2item
  46. Cytochrome P450 (CYP450) 3item
  47. Ksp 1 item
  48. ErbB 1 item
  49. Survivin 1 item
  50. c-MET 1 item
  51. PKC 2item
  52. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  53. HER2 2item
  54. USP 1 item
  55. PARP 1 item
  56. ALK 1 item
  57. ROS1 1 item
  58. D1 and D5 Receptors 1 item
  59. D2 Receptors 1 item
  60. D3 Receptors 1 item
  61. MELK 1 item
  62. CSF1R 1 item
  63. Autophagy 1 item
  64. ATM/ATR 2item
  65. COX 1 item
  66. Heparanases 1 item
  67. CK2 1 item
  68. HIPK2 1 item
  69. HIPK3 1 item
  70. HIV Integrases 1 item
  71. PRAK 1 item
  72. MAPKAP-K2 1 item
  73. Guanine nucleotide exchange factors (GEFs) 1 item
  74. 20S proteasomal chymotrypsin 1 item
  75. Geranylgeranyltransferase I 1 item
  76. Farnesyltransferase 1 item
  77. Carbonic Anhydrases 1 item
  78. Histone Demethylases 1 item
  79. Insulin Receptors 1 item
  80. IRG-1R 1 item
  81. eEF-2 1 item
  82. D4 Receptors 1 item
  83. DPP-4 1 item
  84. Aromatases 2item
Reported Experiments
  1. Animal Experiments 113item
  2. Cell Experiments 71item